Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative

Abstract:
Initiates Rosetta Green, a Project Which Will Leverage Rosetta Genomics' Proprietary microRNA Technologies and Strong IP Position to Develop a Wide Range of Plant-Based Applications

The Company has Recently Secured Up to $1.5M From Private Investors, Which Will be Invested in the Project in Trenches as Certain Milestones are Reached

Rosetta has Already Identified microRNAs Correlated With Algal Oil Content and Starch & Oil Content in Corn

Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative

REHOVOT, Israel and JERSEY CITY, NJ | Posted on October 27th, 2008

Rosetta Genomics Ltd (Nasdaq:ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today it has launched Rosetta Green, a microRNA-based plant biotechnology project. Rosetta Green will leverage the extensive knowledge gained at Rosetta Genomics in microRNAs, as well as its proprietary technologies and strong IP position, to develop a wide range of plant-based applications. The company has recently completed a financing round from private investors exclusively for this project.

"Since our founding in 2000, we have maintained that small non-protein coding RNA - what we now know are microRNAs - play a critical role in many cellular processes," said Amir Avniel, CEO of Rosetta Genomics. "There is a large and growing body of evidence, including research we have been conducting in-house, pointing to the importance of microRNAs in plants and algal development, which may have potential applications in a wide range of plant-based biotech products. We feel it is critical at this point in time to explore this important field to ensure Rosetta Genomics remains at the forefront of research, development and commercialization of microRNA-based products."

MicroRNAs have been established as key regulators of protein expression and their aberrant regulation in humans is associated with many serious diseases. However, microRNAs' vast potential is not limited to humans.

Research conducted at Rosetta Green has shown a promising correlation between the expression of microRNAs and algal oil content. In addition, correlation has been found between microRNAs and starch & oil content in corn.

"MicroRNAs hold significant potential for the plant biotechnology industry," noted Dr. Rudy Maor, Head of Research and Development at Rosetta Green. "Stemming from their role as master regulators of gene expression, microRNAs are believed to play a critical role in each major step in plant and algal development and may therefore affect biotech-related traits such as oil and starch content, stress-tolerance, growth rate, yield, and more."

"Using Rosetta Genomics' unique microRNA technologies and strong IP, our goal is to develop a wide range of solutions that will assist companies in addressing critical unmet needs, " said Dr. Dalia Cohen, Chief Scientific Officer at Rosetta Genomics. "Through collaborations with strategic partners in the plant biotech industry, we intend to develop novel solutions using the unique potential microRNAs hold."

About microRNAs

MicroRNAs (miRNAs) are naturally occurring, short non-coding RNAs that regulate gene expression in plants, humans, and have been recently discovered in algae. The ability to selectively regulate gene expression through microRNAs could provide the means to enhance a wide range of plant and algal characteristics which are of high value to the plant biotech industry.

####

About Rosetta Genomics Ltd
Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNAs. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications. The first microRNA diagnostic test applying Rosetta Genomics' technology has been approved for clinical use by the State of New York, and the company expects it will be launched by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to: the potential to use microRNA-based molecular breeding to develop algal strains and non-food crops for improved biofuel production; the receipt of additional financing when certain milestones have been met and the role of microRNAs in plant and algal physiology and development constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including the risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.

For more information, please click here

Contacts:
Business Development
Yoram Bouskila
T: +972-73-222-0726


Media & Investors
Ron Kamienchick
T: +972-73-222-0700

Copyright © Rosetta Genomics Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano-supercapacitors for electric cars July 25th, 2014

New imaging agent provides better picture of the gut July 25th, 2014

Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster: University of Leicester research team unlocks insights into creation of new nano-materials July 25th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

Announcements

Nano-supercapacitors for electric cars July 25th, 2014

New imaging agent provides better picture of the gut July 25th, 2014

Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster: University of Leicester research team unlocks insights into creation of new nano-materials July 25th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

Patents/IP/Tech Transfer/Licensing

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

Rice's silicon oxide memories catch manufacturers' eye: Use of porous silicon oxide reduces forming voltage, improves manufacturability July 10th, 2014

Food/Agriculture/Supplements

Key Announcements made at TAPPI International Nanotechnology Conference July 7th, 2014

Squid sucker ring teeth material could aid reconstructive surgery, serve as eco-packaging July 2nd, 2014

FDA issues guidance on use of nanotechnology in foods July 1st, 2014

Shaken, not stirred -- mythical god's capsules please! June 26th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE